1. Zhang Y, Proenca R, Maffei M: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425, 1994
2. Chen H, Charlat O, Tartaglia LA: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491, 1996
3. Elmquist JK, Elias CF, Saper CB: From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221, 1999
4. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395: 763, 1998
5. Flier JS: Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 83:1407, 1998
6. Ahima RS, Flier JS: Leptin. Annu Rev Physiol 62:413, 2000
7. Haynes WG: Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypert Report 2:311, 2000
8. Sethi J, Hotamisligil GS: The role of TNFa in adipocyte metabolism. Semin Cell Dev Biol 10:19, 1999
9. Hotamisligil GS, Arner P, Caro JF: Increased adipose expression of human tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409,
10. Grunfeld C, Feingold KR: Regulation of lipid metabolism by cytokines during host defense. Nutrition 12: S24, 1996
11. Stouthard JM, Romijn JA, Van Der Poll T: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268: E813, 1995
12. Shimomura I, Funahashi T, Takahashi M: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2, 800, 1996
13. Karlsson C, Lindell K, Ottoson M: Human adipose tissue expresses angiotensinogen and enzymes required for its conversion angiotensin II. J Clin Endocrinol Metab 83: 3925, 1998
14. Frederich RC, Kahn BB, Peach MJ: Tissue specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 19:339, 1992
15. Flier JS, Lowell B, Napolitano A: Adipsin: regulation and dysregulation in obesity and other metabolic states. Recent Prog Horm Res 45:567, 1987
16. Napolitano A, Lowell BB, Damm D: Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 18: 213, 1994
17. Cianflone K, Maslowsk M, Sniderman AD: Acylation stimulation protein (ASP), an adipocyte autocrine: new directions. Stem Cell Dev Biol 10:31, 1999
18. Scherer PE, Williams S, Fogliano M: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746, 1995
19. Matsuzawa Y, Funahashi T, Nakamura T: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-dervied bioactive substances. Ann New York Acad Sci 892:146, 1999
20. Hotta K, Funahashi T, Arita Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595, 2000
21. Siiteri PK: Adipose tissue as a source of hormones. Am J Clin Nut 45 (Suppl.1): 277, 1987
22. Katz JR, Mohamed-Ali V, Wood PJ: An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol. 50: 63, 1999
23. Rebuffé-Scrive M, Brönneguard M, Nilsson A: Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215, 1990
24. Mizutani T, Nishikwa Y, Adachi H: Identification of estrogen receptor in human adipose tissue and adipocytes. J Clin Endocrinol Metab 78:950, 1994
25. Pederson SB, Fuglsig S, Sjögren P: Identification of steroid receptors in human adipose tissue. Eur J Clin Invest 26:1051, 1996
26. Wabitsch M, Blum WF, Muche R: Contribution of androgens to gender difference in leptin production in obese children and adolescents. J Clin Invest 100:808, 1997
27. Watibsch M, Jensen PB, Blum WF: Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45:1435, 1996
28. Barrett-Connor E, Khaw KT: Endogenous sex hormones and cardiovascular disease in men: A prospective population based study. Circulation 78:539, 1988
29. Haffner SM, Valdez RA, Stern MP: Obesity, body fat distribution and sex hormones in men. Int J obes Relat Metab Disord 17:643, 1993
30. Seidell JC, Bjorntorp P, Sjostrom L: Visceral aft accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39:897, 1990
31. Stanik S, Korenman SG, Dornfeld L: Weight loss normalizes the sex steroid imbalance of obese men. Proc Endo Soc 60th Ann Meeting. 1978 Abstract 259
32. Strain GW, Zumoff B, Miller LK: Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men. J Clin Endocrinol Metab 66:1019, 1988
33. Barbato AL, Landau RL: Testosterone deficiency of morbid obesity. Clin Res 22:647A, 1974
34. Glass AR, Swerdloff RS, Bray GA: Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 45:1211, 1977
35. Schneider G, Kirschner MA, Berkowitz R, et al: Increased estrogen production in obese men. J Clin Endocrinol Metab 48:633-638, 1979
36. Amatruda JM, Hochstein M, Hsu TH: Testosterone deficiency of morbid obesity: possible role of the hypothalamus. Clin Res 24:571A, 1975
37. Isidori AM, Caprio M, Strollo F: Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 84:3673, 1999
38. Kley HK, Solbach HG, McKinnan JC: Testosterone decrease and estrogen increase in male patient with obesity. Acta Endocrinol 91:553, 1979
39. Tchernof A, Despres JP, Belanger A: Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 44:513, 1995
40. Tenover JL: Experience with testosterone replacement in the elderly. Mayo Clinic Proc 75:577, 2000
41. Goldzieher JW, Axelrod LR: Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 49:514, 1963
42. Marsden PJ, Murdoch AP, Taylor R: Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol 55:191, 2001
43. Toprak S, Yonem A, Cakir B: Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55:65, 2001
44. Dale PO, TanboT, Vaaler S: Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58:487, 1992
45. Evans DJ, Hoffman RG, Kalkhoff RK: Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 57:304, 1993
46. Kissebah AH, Vydelingum N, Murray R: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254, 1982
47. Nestler JE, Barlascini CO, Matt DW: Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027, 1989
48. Nestler JE, Powers LP, Matt DW: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 72:83, 1991
49. Diamanti-Kandarakis E, Kouli C, Tsianateli T: Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138:269, 1998
50. Morin-Papunen LC, Koivunen RM, Ruokonen A: Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women polycystic ovary syndrome. Fertil Steril 69:691, 1998
51. Nestler JE, Jakubowicz DJ, Evans WS: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 25:1876, 1998
52. Sitteri PK, MacDonald PC: Role of extraglandular estrogen in human endocrinology, in Handbook of Physiology sect 7, volume 2. Washington, American Physiological Society, 1973, pp615-629
53. Edman CD, MacDonald PC: Effects of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130:456, 1978
54. Strain GW, Zumoff B, Levin J: Estradiol metabolism of massively obese women. Clin Res 25:541A, 1977
55. Fishman J, Boyar RM, Hellman L: Influence of body weight on estradiol metabolism in young women. J Clin Endocrinol Metab 41:989, 1975
56. Dignam WJ, Parlow AF, Daane TA: Serum FSH and LH measurements in the evaluation of menstrual disorders. Am J Obst Gynecol 105:679, 1969
57. Kopelman PG, Pikington TRE, White N: Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol 12:363, 1980
58. Spritzer PM, Poy M, Wiltgen D: Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Rep 16:1340, 2001
59. Strata A, Ugullotti G, Contini C: Thyroid and obesity: Survey of some function tests in a large obese population. Int J Obes 2:333, 1978
60. Wilcox RG: Triiodothyronine, TSH, and prolactin in obese women. Lancet 1:1027, 1977
61. Felt V, Strasek J, Bednar J: Thyroid hormones and obesity. Rev Czech Med 22:216-224, 1976
62. Bray GA, Fisher DA, Chopra IJ: Relation of thyroid hormones to body weight. Lancet 1:1206, 1976
63. Danforth E, Horton ES, O'Connell M: Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 64:1336, 1979
64. Scriba PC, Baver M, Emmert D: Effects of obesity, total fasting, and realimentation on l-thyroxine (T4), 3,5,3´-L-Triiodothyronine (T3), 3,3´,5´-L-Triiodothyronine (rT3), Thyroxine binding globulin (TBG), cortisol, thyrotropin, cortisol binding globulin (CBG), transferrin, a2-Haptoglobin and complement C´3 in serum. Acta Endocrinol 91:629, 1979
65. Spaulding SW, Chopra IJ, Sherwood RF: Effects of caloric restriction and dietary composition on serum T3 and reverse T3 in man. J Clin Endocrinol Metab 42:197, 1976
66. Azizi F: The effect of dietary composition on fasting induced changes in serum thyroid hormones and thyrotropin. Metabolism 27:935, 1978
67. Burman KD, Harvey GS, O'Brian JT: Glucose modulation of alterations in peripheral thyroid hormone metabolism induced by fasting. Metabolism 28:291, 1979
68. Carlson HE, Drenick EJ, Chopra IJ: Alterations in basal and TRH stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J Clin Endocrinol Metab 45:707, 1977
69. Donders SHJ, Pieters GFFM, Heevel JG: Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity. J Clin Endocrinol Metab 61:56, 1985
70. Pasquali R, Baraldi G, Biso P: Effect of 'physiological' doses of triiodothyronine replacement on the hormonal and metabolic adaptation to short-term semistarvation and to low-calorie diet in obese patients. Clin Endocrinol 21:357, 1984
71. Byerley LO, Heber D: Metabolic effects of triiodothyronine replacement during fasting in obese subjects. J Clin Endocrinol Metab 81:968, 1996
72. Krotkiewski M, Holm G, Shono N: Small doses of triiodothyronine can change some risk factors associated with abdominal obesity. Int J obes 21:922, 1997
73. Strain GW, Zumoff B, Strain JJ: Cortisol production in obesity. Metabolism 29:980, 1980
74. Kobberling J, Von zur Muhlen A: The circadian rhythm of free cortisol determined by urine sampling at two-hour intervals in normal subjects and in patients with severe obesity or Cushing's syndrome. J Clin Endocrinol Metab 38:313, 1974
75. Galvao-Teles A, Graves L, Burke CW: Free cortisol in obesity: Effect of fasting. Acta Endocrinol 81:321, 1976
76. Copinschi G, DeLaet MH, Brion JP: Simultaneous study of cortisol, growth hormone, and prolactin nyctohemeral variations in normal and obese subjects: Influence of prolonged fasting in obesity. Clin Endocrinol 9:15, 1978
77. Stewart PM: 11 b-hydroxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol (Oxf) 44:493, 1996
78. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect 'Cushing's disease of the momentum' ? Lancet 349:1210, 1997
79. Rosmond R, Dallman MF, Björntorp P: Stress-related cortisol secretion in men: relationship with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853, 1998
80. Streeten DHP, Stevenson GT, Dalakos TG: The diagnosis of hypercortisolism: Biochemical criteria differentiating patients form lean and obese normal subjects and from females on oral contraceptives. J Clin Endocrinol Metab 29:1191, 1969
81. Pasquali R, Vicennati V: Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Internat J Obes 24:S47, 2000
82. Rosmond R, Chagnon YC, Holm G: A glucocorticoid receptor gene marker is
associated with abdominal obesity, leptin, and dysregulation of the hypoyhalamic-pituitary-adrenal
axis. Obes Res 8:211, 2000
83. Björntorp P, Rosmond R: Neuroendocrine abnormalities in visceral
obesity. Internat J Obesity 24:S80, 2000
84. Jessop DS, Dallman MF, Fleming D: Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab 86:4109, 2001
85. Iranmanesh A, Lizarralde G, Veidhuis JD: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 73:1081, 1991
86. Copinschi G, Wegienka LC, Hane S: Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metab 16:485, 1967
87. Bell JP, Donald RA, Espiner LA: Pituitary response to insulin-induced hypoglycemia in obese subjects before and after fasting. J Clin Endocrinol Metab 31:546, 1970
88. Cordido F, Penalva A, Dieguez C: Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 96:819, 1993
89. Holt R, Webb E, Pentecost C: Aging and Physical Fitness Are More Important Than Obesity in determining Exercise-Induced Generation of GH. J Clin Endocrinol Metab 86:5715, 2001
90. Kanaley JA, Weatherup-Dentes MM, Jaynes EB: Obesity Attenuates the Growth Hormone Response to Exercise. J Clin Endocrinol Metab 84:3156, 1999
91. Rasmussen MH, Hvidberg A, Juul A: Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-1 levels in obese subjects. J Clin Endocrinol Metab 80:1407, 1995
92. Kelijman M, Froliman LA: Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab 66:489, 1988
93. Frystyk J, Vestbo E, Skjaerbaek: Free insulin-like growth factors in human obesity. Metabolism 44:37-44, 1995
94. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Metabolism 30: 89, 1981.
95. Maccario M, Tassone F, Gauna C: Effects of short-term administration of low-dose rhGH on IGF-1 levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol 144:251, 2001
96. Maccario M, Tassone F, Gianotti L: Effects of recombinant human insulin-like growth factor 1 administration on the growth hormone (gh) response to GH-reelasing hormone in obesity. J Clin Endocrinol Metab 86:167, 2001
97. Lee EJ, Nam SY, Kim KR: Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acids in normal and obese subjects. J Clin Endocrinol Metab 80:2495, 1995
98. Dieguez C, Carro E, Seoane LM: Regulation of somatotroph cell function by the adipose tissue. Internat J Obes 24:S100, 2000
99. Ferrannini E, Natali A, Bell P: Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166, 1997
100. Diabetes Prevention Program Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 346:393, 2002
101. Evans DJ, Hoffman RG, Kalkhoff RK: Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33:68, 1984
102. Bonora E: Relationship between regional fat distribution and insulin resistance. Internat J Obes 24:S32, 2000
103. Polonsky KS: Dynamics of insulin secretion in obesity and diabetes. Internat J Obes 24:S29, 2000
104. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3, 1997
105. Gorden ES: Non-esterified fatty acids in blood of obese and lean subjects. Am J Clin Nutrition 8:740, 1960
106. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependant diabetes. J Clin Invest 96:1261, 1995
107. Dresner A, Laurent D, Marcucci M : Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinas activity. J Clin Invest 103:253, 1999
108. Hotamisligil GS, Spiegelman BM: Tumore necrosis factor a key component of the obesity-diabetes link. Diabetes 43:1271, 1994
109. Kroder G, Bossenmaier B, Kellerer M: Tumor necrosis factor-alpha and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471, 1996
110. Bluher M, Kratzsch J, Paschke R: Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diab Care 24:328, 2001
111. Pincelli AI, Brunani A, Scacchi M: The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistance. Horm Res 55:57, 2001
112. Tsiotra PC, Tsigos C, Raptis SA: TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Internat J Obes 25:1018, 2001
113. Savage DB, Sewter CP, Klenk ES: Resistin / Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator-Activated Receptor-g Action in Humans. Diabetes 50:2199, 2001
114. Nagaw I, Smith U: Insulin resistance and type 2 diabetes are not related to Resistin expression in human fat cells or skeletal muscle. Biochem & Biophysic Res Commun 285:561, 2001
115. Borglio F, Arvat E, Benso A: Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083, 2001
116. Tschöp M, Weyer C, Tataranni PA: Circulating Ghrelin levels are decreased in human obesity. Diabetes 50:707, 2001
117. Horvath TL, Diano S, Sotonyi P: Minireview: Ghrelin and the Regulation of Energy Balance-A Hypothalamic Perspective. Endocrinol 142:4163, 2001